Intra-abdominal Infections Market: Global Product Intelligence, Analysis, Opportunities and Forecast to 2025

Intra-abdominal Infections Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of intra-abdominal infections market by diagnosis (blood tests, abdominal X-ray, computed tomography, ultrasound), drugs (metronidazole, clindamycin, chloramphenicol, ceftriaxone) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the intra-abdominal infections market it includes the five years industry analysis and the 6 years annual forecast from 2019 to 2025. The global intra-abdominal infections market is projected to grow at a CAGR of 5.10% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @

Intra-abdominal Infections Market: Industry Insight

Intra-abdominal infections are common surgical emergencies and are a major cause of non-trauma deaths in the emergency departments worldwide. Intra-abdominal infections comprise of a diverse set of diseases such as appendicitis, peptic ulcer disease, and diverticulitis. Treatment of intra-abdominal infections has evolved in recent years because of advances in supportive care, diagnostic imaging, minimally invasive intervention, and antimicrobial therapy. Ultrasound (US) and computed tomography (CT) have been used to complete the clinical assessment of patients with intra-abdominal infections. The drugs used in the intra-abdominal infection include Clindamycin, Metronidazole, Chloramphenicol, Aztreonam, Ceftriaxone, Ciprofloxacine, Gentamycine, and several others.

Intra-abdominal Infections Market: Drivers and Restraints

Complicated intra-abdominal infections are an important cause of morbidity and mortality. It is the second most commonly identified cause of severe sepsis in the intensive care unit. The growing awareness about the intra-abdominal infections is driving the growth of the intra-abdominal infections market. Furthermore, 30% of people are diagnosed with diverticulitis by age 60 years and the rising elderly population with an increased risk of intra-abdominal infections drives the growth of the market. However, low awareness about such conditions in developing and underdeveloped economies hampers the growth of the market. Moreover, an increasing number of abdominal surgeries, trauma patients and people with chronic abdominal inflammatory conditions favors the growth of the intra-abdominal infections market.

Enquire here Get Customization & Check Discount for Report @

Intra-abdominal Infections Market: Regional Insight

North America is the most dynamic, highly competitive and the largest market for the intra-abdominal infections globally. The major driving factor, which has driven the growth of the intra-abdominal infections market in this region, is the rising prevalence of chronic abdominal inflammatory conditions and favorable reimbursement policies. Growth in the region is mainly backed by the U.S followed by Canada and Mexico. Europe is expected to grow at a steady rate within the forecast period. Asia-Pacific region is projected to grow at the highest CAGR during 2019-2025. The rising geriatric population in Japan, increasing medical expenditure and the flourishing healthcare sector in Asia Pacific countries such as China and India are anticipated to fuel the growth of the market.

Intra-abdominal Infections Market: Segmentation

The report on intra-abdominal infection market is segmented on the basis of diagnosis and drugs. The diagnosis segment is further classified into blood tests, abdominal x-ray, computed tomography (CT) and ultrasound. Among them, ultrasound holds a significant share in the market owing to its wide use in the diagnosis of abdominal inflammatory conditions. The drugs used in the intra-abdominal infection include Metronidazole, Clindamycin, Chloramphenicol, Ceftriaxone, Aztreonam, Ciprofloxacine, Gentamycine, and several others.

Browse Detailed TOC and Description of this Exclusive [email protected]

Intra-abdominal Infections Market: Competitive Analysis

The major players in the intra-abdominal infections market include AstraZeneca Plc., Merck & Co., Inc., Pfizer Inc, AtoxBio Inc., Teva Pharmaceutical Industries Ltd., Dainippon Sumitomo Pharma, Bayer Healthcare Pharmaceutical Inc., and Bristol Myers Squibb Company.

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the intra-abdominal infections.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Related Articles